Navigation Links
Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
Date:11/10/2008

644,611

leasehold inducement (2,858) (2,858)

Stock-based compensation expense 643,548 324,790

Loss on disposal of capital assets 10,294 -

Unrealized foreign exchange (gain) loss (373,484) 15,497

Accrued interest on held-to-maturity

investments (174,597) (442,382)

Net change in operating assets and liabilities (1,015,958) (1,573,987)

-------------------------------------------------------------------------

Cash used in operating activities (5,112,104) (5,074,103)

-------------------------------------------------------------------------

INVESTING ACTIVITIES

Maturity of short-term investments 108,145,816 161,473,726

Purchase of short-term investments (98,473,182) (160,529,878)

Purchase of capital assets (43,317) (3,247)

Purchase of intangible assets (1,131,280) -

Proceeds on disposal of capital assets 48,161 -

-------------------------------------------------------------------------

Cash provided by investing activities 8,546,198 940,601

-------------------------------------------------------------------------

FINANCING ACTIVITY

Proceeds from issuance of common shares, net 125,551 24,038,446

-------------------------------------------------------------------------

Cash provided by financing activity 125,551 24,038,446

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Impact of foreign exchange on cash and cash

equivalents 372,996 (15,497)

---
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Respiratory Leaders Urge Medical Community to Educate Patients Transitioning CFC to HFA Inhalers
2. Transitions Optical to Provide Free Vision Screenings at the American Diabetes Associations Feria de Salud por tu Familia(TM)
3. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
4. Schering-Plough Announces Transition of Animal Health Leadership
5. ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program
6. MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America
7. Transition Therapeutics Announces No Material Change
8. Transitions Optical Offers Tips on How to Protect Eyes for Outdoor Sports Fans
9. Transition Therapeutics Announces Executive Management Appointments
10. AGA Medical Announces Management Transition
11. Booth Radiology Associates Chooses IDC To Complete Its Transition To Digital Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... ... with its Topricin® Pain Relief and Healing Cream designated as the nonprofit’s natural ... that is actively addressing Line of Duty Deaths (LODD) and the high rate ...
(Date:7/29/2015)... Miami, FL (PRWEB) , ... July 29, 2015 , ... ... on fruit flies revealed a gene which is directly responsible for stimulating and perpetuating ... was published in the journal entitled Proceedings of the National academy of Sciences, and ...
(Date:7/29/2015)... ... 29, 2015 , ... On July 26th the Miami ... for nicotine laced liquid products. Their report says cigarette use has decreased recently ... particularly troublesome to addiction professionals as many of the candy flavors available are ...
(Date:7/29/2015)... MI (PRWEB) , ... July 29, 2015 , ... ... for Southwest Michigan, changed its name in July to Kalamazoo Strength & Conditioning. ... http://www.kalamazoosc.com , and “reflects the evolution of our training center over the ...
(Date:7/29/2015)... , ... July 29, 2015 , ... San Fernando ... on Ultherapy. For a limited time only, patients can get the complete treatment process ... for patients who prefer a non-invasive treatment and have loose or sagging skin. ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2
... San Diego, Calif., USA Today, during the 89th ... Dental Research, held in conjunction with the 40th Annual ... the 35th Annual Meeting of the Canadian Association for ... oral presentation on a research study titled "Sealing Manifest ...
... Reporter , THURSDAY, March 17 (HealthDay News) -- Cutting-edge ... tremors, rigidity and other motor skill problems that are ... The phase 2 study enrolled 45 patients with ... to receive the gene therapy and half assigned to ...
... March 17, 2011 (BRONX, NY) The National Institutes ... Albert Einstein College of Medicine and Ferkauf Graduate ... identify cognitive factors that influence mobility in older people ... people remain active. , "Mobility limitations and disability in aging ...
... 2011) Many Baby Boomers will experience a bone fracture as ... prepared to provide the necessary care required, according to a ... Geriatric Orthopaedic Surgery and Rehabilitation (GOS), published by SAGE. ... II Baby Boom generation will reach 65 years old this ...
... at the University of Cincinnati (UC) and Cincinnati ... FDA-approved drug sirolimus, used primarily to prevent rejection ... women with lymphangioleiomyomatosis (LAM). The Multicenter International ... first randomized, controlled study designed to develop a ...
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay ... reached an all-time low in 2009, the 10th straight ... health officials report. , "There is basically good news," ... U.S. Centers for Disease Control and Prevention,s National Center ...
Cached Medicine News:Health News:Sealing manifest occlusal caries in permanent teeth -- 2.5-year results 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 3Health News:$3.4 million grant awarded to help older people stay mobile 2Health News:US healthcare system can't keep up with number of baby boomers' bone fractures 2Health News:New therapy found for rare lung disorder 2Health News:New therapy found for rare lung disorder 3Health News:U.S. Death Rate at All-Time Low: CDC 2Health News:U.S. Death Rate at All-Time Low: CDC 3
(Date:7/29/2015)... 2015   KaloBios Pharmaceuticals, Inc . (Nasdaq: ... innovative therapies to benefit patients with diseases of unmet ... that the U.S. Food and Drug Administration (FDA) has ... KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with ... now active. The acceptance of this IND ...
(Date:7/29/2015)... 27, 2015 Research and Markets ( http://www.researchandmarkets.com/research/sxwk89/3d_metrology ... Metrology Market by Product (CMM, ODS, and VMM), Application ... Geography (North America, Europe, APAC, RoW) - Global Forecast ... The 3D metrology market was valued at ... at a rate of 7.11% during the forecast period. ...
(Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) ... centralize Inferior vena cava (IVC) Filter lawsuits filed against ... have already been centralized by the JPML. ... risk for a pulmonary embolism. The filters are designed ... Claims against Bard and Cook involve incidents of retrievable ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Global 3D Metrology Market 2015-2020: Products (CMM, ODS, and VMM) & Applications (Automotive, Aerospace, Energy & Power, Medical and Electronics) 2IVC filter litigation continues; law firm provides free information to IVC filter patients 2
... , , , ... AMGN ) today announced positive top-line results from a pivotal ... acid) administered as an intravenous (IV) infusion in the treatment of ... including breast and prostate cancer) or multiple myeloma. , ...
... , , , , ... Institute (KLRI) has published two new publications on hormone therapies and ... adults. , , Cardiovascular disease caused by atherosclerosis, ... greatest single killer of American women--40% of total deaths--and the rate ...
Cached Medicine Technology:Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 2Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 3Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 4Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 5Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 6Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 7Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 8TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 2TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 3
... Examination Tables deliver the highest quality care to ... types of patients can face a frustrating dilemma ... the exam table. Being able to easily get ... comfort during the exam, help the physician conduct ...
... This site introduces the DiamondTome™ ... with its unique DiamondTome™ Wands, an ... better way to smoother, more youthful ... we present the benefits of DiamondTome's™ ...
... Expand your practice with the advantages of ... effective treatment of leg veins and other deeper ... and fast. As a stand alone device or ... the Quantum DL treats a range of conditions ...
Inquire...
Medicine Products: